Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1

This publication has 91 references indexed in Scilit:

• NALT (nasal cavity-associated lymphoid tissue) in the rabbit
  Veterinary Immunology and Immunopathology, 2010
• Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
  PLOS ONE, 2009
• Vaccination With Agonist Peptide PSA: 154-163 (155L) Derived From Prostate Specific Antigen Induced CD8 T-Cell Response to the Native Peptide PSA: 154-163 But Failed to Induce the Reactivity Against Tumor Targets Expressing PSA
  Journal of Immunotherapy, 2009
• Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
  PLOS ONE, 2008
• In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity
  Infection and Immunity, 2007
• A dose–response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
  Vaccine, 2007
• Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide
  Biologicals, 2005
• NALT- versus PEYER'S-patch-mediated mucosal immunity
  Nature Reviews Immunology, 2004
• Technologies to Improve Immunisation Safety
  Drug Safety, 2001
• Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic Effects
  The International Journal of Cell Cloning, 1996